Igene Labserve Profile
Key Indicators
- Authorised Capital ₹ 0.15 M
- Paid Up Capital ₹ 0.15 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.25 Cr
- Revenue Growth 62.13%
- Profit Growth 33.35%
- Ebitda -13.49%
- Net Worth 75.17%
- Total Assets 97.70%
About Igene Labserve
Igene Labserve Private Limited (ILPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 06 March 2018 (Six years and ten months 27 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.15 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹5.25 Cr.
Karni Mundhra and Yogita Yadav serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33300DL2018PTC330364
- Company No.
330364
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Igene Labserve Private Limited offer?
Igene Labserve Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, Lab Incubator, Thermometers & Flowmeters, Viscosity Instruments, Laboratory & Lab Equipment, Laboratory Stirrer, Industrial Air Conditioner & Devices, Chillers, Laboratory & Pharmaceutical Ovens, Medical Laboratory Instruments.
Who are the key members and board of directors at Igene Labserve?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karni Mundhra  | Director | 06-Mar-2018 | Current |
| Yogita Yadav | Director | 06-Mar-2018 | Current |
Financial Performance of Igene Labserve.
Igene Labserve Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 62.13% increase. The company also saw a substantial improvement in profitability, with a 33.35% increase in profit. The company's net worth Soared by an impressive increase of 75.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Igene Labserve?
Unlock access to Igene Labserve's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹52.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
- Hdfc Bank Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2022 | Hdfc Bank Limited | ₹2.50 M | Open |
| 31 May 2022 | Others | ₹5.00 Cr | Open |
How Many Employees Work at Igene Labserve?
Igene Labserve has a workforce of 59 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Igene Labserve, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Igene Labserve's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
